جستجوی استاد راهنمای دانشگاهی

Hasan Samra is an Assistant Professor at Augusta University’s Medical College of Georgia, specializing in the Department of Pathology with a focus on Clinical Pathology. His academic and clinical work bridges diagnostic pathology with infectious diseases, emphasizing rare and complex infections in immunocompromised populations. Education: MD from Syrian Private University (2014) Certifications: Georgia Professional Licensing (BRD, 2021) Dr. Samra’s research explores emerging infectious diseases, fungal and bacterial pathogenesis, and molecular diagnostics. He investigates rare infections like mucormycosis, listerial peritonitis, and Naegleria fowleri, often in high-risk patients such as those with diabetes, hematologic malignancies, or post-transplant conditions. His work also addresses public health challenges, including undiagnosed AIDS in pediatric monkeypox cases and post-disaster infections. Publications highlight trends in invasive fungal sinusitis, prosthetic joint infections, and rapid diagnostic methods like the Idylla system. His scholarship emphasizes precision medicine, antimicrobial stewardship, and improving diagnostic protocols for challenging cases. He teaches Clinical Pathology (PATH 5009) and contributes to institutional policies on surgical pathology examination standards.

• Infectious Diseases
• Clinical Pathology
• Medical Microbiology
• +۵ مورد دیگر

Emmanuel Ho is a Professor at the University of Waterloo and serves as the Associate Director of Graduate Studies & Research. His research focuses on nanomedicine and vaccine delivery, with expertise in drug delivery systems, polymer chemistry, and biomaterials. He leads the Ho Research Group, dedicated to developing innovative biomedical technologies for healthcare challenges. His work integrates materials science, pharmacology, and engineering to address issues in infectious diseases, ocular health, and drug delivery mechanisms. Key research areas include the design of smart polymers for targeted drug delivery, development of biosensors for rapid pathogen detection, and the application of nanotechnology in combating antimicrobial resistance. His projects often involve interdisciplinary collaborations, such as combining machine learning with nanoparticle formulation design to optimize therapeutic efficacy. Recent advancements from his lab include microwave biosensors for E. coli detection, bacteria-responsive drug release platforms, and pH-sensitive nanomicrobicides for HIV prevention. These innovations highlight his commitment to translating cutting-edge science into practical medical solutions. The Ho Research Group’s work has been widely published in top-tier journals, reflecting its impact on both academic and clinical fields.

• Nanomedicine
• Vaccine Delivery
• Drug Delivery Systems
• +۳ مورد دیگر

Hans-Gustaf Ljunggren is Professor and Senior Physician at the Department of Medicine, Huddinge, Karolinska Institutet (KI) in Sweden, where he has served since 2001. In parallel he founded and directs the Center for Infectious Medicine (CIM) . He is additionally a part-time visiting professor at Nova Southeastern University, USA (2017-2019), and an elected member of the Academia Europaea (2023). Education & Training: MD and PhD, Karolinska Institutet, 1982-1992 Post-doctoral fellowship, Center for Cancer Research, MIT, Boston, USA, 1992-1994 Research Focus His group investigates human immune responses in cancer and infectious diseases , with emphasis on natural-killer (NK) cell biology, innate and adaptive immunity, and immunotherapeutic applications. Major themes include: NK-cell reactivity against tumors and NK-cell–based cancer immunotherapy Immunity to flaviviruses (TBEV, JEV, YFV) and SARS-CoV-2 Vaccine immunogenicity in healthy and immunocompromised populations Genetic and functional studies of cytotoxic lymphocyte defects Scientific Awards & Honors Cancer Research Institute Post-Graduate Fellowship, New York (1990) J William Fulbright Foreign Scholarship Award (1992) Distinguished Professor Recognition, Karolinska Institutet (2010) Tobias Foundation Prize, Royal Swedish Academy of Sciences (2011) Medal for Zealous and Devoted Service to the Swedish Government (2020) Leadership & Service Prof. Ljunggren has held numerous leadership roles at KI, including member of the Nobel Assembly, Dean of Research (2013-2016), and currently Director of the NextGenNK Competence Center founded by Sweden’s Innovation Agency. He has served on editorial boards, national grant panels, and as scientific secretary of the Swedish Cancer Society.

• Tumor immunity
• Infection immunity
• Innate immunity
• +۳ مورد دیگر

Revati Masilamani, Ph.D., is an Assistant Professor in Medical Education at the Tufts University School of Medicine. She holds dual appointments at the School of Medicine and Tisch College, both located at 120 Harrison Avenue, Boston, MA. Her work focuses on advancing medical education through innovative teaching and mentorship models. Dr. Masilamani teaches a wide range of courses including Intro to Microbiology Immunology Cell Biology Neurobiology topics like 'Neural Signaling' and 'Neurobiology of Addiction' Lab Science Investigations Her courses emphasize interdisciplinary approaches to biomedical sciences and health careers. Her research interests span medical education strategies, immunology, and microbiology with a focus on vaccine development and genetic interactions in pathogens like Streptococcus pneumoniae. She also explores mentorship models to foster inclusive pathways to healthcare professions. This profile currently contains no listed scientific awards or grants. Dr. Masilamani's work includes collaborations with Tisch College and Tufts Summer Accelerator programs, though specific lab affiliations are not explicitly mentioned in the provided text.

• Medical Education
• Immunology
• Microbiology
• +۵ مورد دیگر

Professor Jeremy Bagg is Professor of Clinical Microbiology and Head of Glasgow Dental School at the University of Glasgow since January 2005. He also serves as Deputy Head of the School of Medicine, Dentistry & Nursing. With a distinguished career spanning over four decades, Professor Bagg has made significant contributions to oral microbiology, infection control, and public health dentistry. Professor Bagg qualified BDS (Hons) from the University of Edinburgh in 1979 and was awarded a PhD in 1982 for research on bacterial adhesion mechanisms. He served as Lecturer in Oral Medicine & Oral Pathology at Cardiff Dental School from 1983-1991, gaining the FDS diploma and MRCPath in oral microbiology in 1987. Joining the University of Glasgow in 1991 as Lecturer in Oral Microbiology, he was awarded a Personal Professorship in Clinical Microbiology in 1999. His research focuses on the role of oral micro-organisms in systemic disease, oral infections in medically compromised patients, infection control in dental surgery, and public health microbiology. As a member of the Infection & Immunity Research Group, Professor Bagg has co-authored two textbooks and published over 160 papers. His work spans dental microbiology, infection control practices, oral-systemic health connections, and global oral health policy development, with particular expertise in denture microbiology, blood-borne virus management, and the oral health of medically compromised patients. Professor Bagg holds significant leadership positions including Chairman of the National Dental Advisory Committee at the Scottish Government Health Department and Chair of the Steering Group of the Scottish Dental Clinical Effectiveness Programme. He is also a member of the UK Advisory Panel for Health Care Workers Infected with Blood-borne Viruses. In 2004, he was awarded the Fellowship of the Faculty of Public Health for his contribution to public health microbiology. His recent work demonstrates continued excellence across multiple domains including dental infection control, global oral health policy, dental education innovation, and the microbiology of oral diseases. Professor Bagg's research has particular relevance to denture care, blood-borne virus management in dental settings, and the connection between oral health and systemic conditions. Professor Bagg has contributed to major initiatives including the Scottish Oral Health Research Strategy and serves as one of two Scottish representatives on the Oral & Dental Specialty Group of the UK Clinical Research Network. His work has influenced dental practice guidelines and public health policy in Scotland and beyond.

• Oral Microbiology
• Clinical Microbiology
• Infection Control
• +۵ مورد دیگر

Maurice Byukusenge is a Clinical Assistant Professor at the Animal Diagnostic Lab , Pennsylvania State University, affiliated with the Department of Veterinary and Biomedical Sciences . His research focuses on zoonotic pathogens, molecular diagnostics, and One Health approaches. Specializations: Infectious diseases, antimicrobial resistance, virology, and genomics. Affiliations: Center for Infectious Disease Dynamics, One Health Microbiome Center. Byukusenge's work spans molecular epidemiology of bacterial pathogens like Brucella , Salmonella , and Escherichia coli , with applications in veterinary diagnostics and public health. His publications highlight the use of genomic tools to track pathogens across species and regions. Key trends in his research include leveraging PCR techniques and whole-genome sequencing for pathogen detection, vaccine development, and understanding zoonotic disease transmission. Collaborative efforts with institutions in Tanzania, Rwanda, and the U.S. underscore his global One Health perspective. He contributes to the Animal Diagnostic Lab , advancing diagnostics for livestock and wildlife diseases. His work intersects with food safety, wildlife health, and antimicrobial resistance mitigation.

• Infectious Diseases
• Veterinary Microbiology
• Antimicrobial Resistance
• +۷ مورد دیگر

PD Dr. Ronald Dijkman is Group Leader of the Experimental Virology Research Group within the Institute for Infectious Diseases (IFIK) at the University of Bern Medical Faculty. His laboratory is located at the Multidisciplinary Center for Infectious Diseases (MCID) , underscoring his central role in Swiss infectious-disease research infrastructure. Education & Training: While the supplied pages do not list explicit degrees, the title PD Dr. indicates that he has completed a PhD, post-doctoral training, and the Germanic Habilitation, qualifying him as an Associate Professor-level faculty member. Research Focus: Dr. Dijkman’s team investigates host–pathogen interactions in the respiratory epithelium , concentrating on three pillars: Innate immunity triggered by influenza and coronaviruses in human and animal airway epithelial cells. Viral genetic determinants that modulate immune evasion and cross-species transmission. Host determinants that either restrict or facilitate infection across species barriers. To dissect these questions, the group has pioneered genetically-tractable, well-differentiated primary airway epithelial cell (AEC) cultures derived from humans, pigs, cattle and bats, creating a unique comparative platform for zoonotic-risk assessment. Funding & Collaborative Networks: His research is currently supported by: Swiss National Science Foundation (SNF) – project on Molecular characterization of Influenza D virus–host interactions . EU Marie Skłodowska-Curie ITN “HONOURs” – a multi-partner training network on host-switching pathogens and zoonoses. Federal BLV grant – implementation of nanopore sequencing for rapid identification of OIE-notifiable animal viruses. These grants enable a team of one post-doc and four PhD students, together with technical staff. Scientific Output & Impact: Since 2010, Dr. Dijkman has authored >60 peer-reviewed articles. His work on SARS-CoV-2 reverse genetics (Nature, 2020), MERS-CoV receptor usage (Nature, 2014) and single-cell influenza pathogenesis (bioRxiv, 2020–22) has been highly cited, reflecting broad scientific impact. Laboratory & Team: The Experimental Virology group occupies BSL-2 and BSL-3 laboratories equipped with state-of-the-art live-cell imaging, lentiviral genetic engineering, and nanopore sequencing pipelines. The group presently comprises: Larise Oberholster – Early Post-doc Alina Baltensperger – PhD student Jean-Claude Makangara – PhD student Mike Javan Mwanga – PhD student Karen Stevers – PhD student Cinzia Moscardelli – laboratory technician

• Respiratory virology
• Coronaviruses
• Influenza viruses
• +۵ مورد دیگر

Rainer Hahn is an Associate Professor in Biochemical Engineering at the Institute of Biochemical Engineering, Department of Biotechnology and Food Sciences, University of Natural Resources and Life Sciences, Vienna (BOKU). He also serves as Head of the Downstream Processing Unit at the BioIndustrial Pilot Plant and is a key researcher at the Austrian Center of Industrial Biotechnology (ACIB). His work is centered on bioprocess engineering with a strong focus on downstream processing and biopharmaceutical purification. University: University of Natural Resources and Life Sciences, Vienna (BOKU) School: Department of Biotechnology and Food Sciences Department: Institute of Biochemical Engineering Role: Associate Professor, Head of Downstream Processing Unit His research interests span Bioprocess Engineering , Downstream Processing , Industrial Biotechnology , Pharmaceutical Technology , and Chemical Biology . He investigates advanced purification techniques, particularly in chromatography and protein separation processes. His recent work emphasizes multicomponent adsorption, protein A affinity systems, and purification of complex biomolecules like secretory immunoglobulin A (sIgA). The trend in his recent publications reveals a strong emphasis on protein purification , chromatographic modeling , and process optimization in biopharmaceutical manufacturing. His work integrates experimental analysis with mathematical modeling to improve efficiency and predictability in downstream operations, especially in multi-component systems. Topics such as continuous chromatography , pH transients , and affinity resin development reflect his leadership in advancing industrial bioprocessing. His notable scientific awards include: HOUSKA PRIZE (Recognition Award) - 2016 Dissertation Prize of the Austrian Society for Biotechnology - 2002 Rainer Hahn has been actively involved in numerous research projects funded by FWF, national enterprises, and private foundations, focusing on biopharmaceutical purification and process development. He mentors students and contributes to academic training through lectures and supervision. He is also a dedicated reviewer for leading journals such as Journal of Chromatography A , Biotechnology and Bioengineering , and Separation and Purification Technology . His work is closely tied to industrial applications, particularly in the development of scalable and efficient biomanufacturing processes. He is associated with the BioIndustrial Pilot Plant and collaborates with ACIB, contributing to innovation in industrial biotechnology. His research group focuses on developing robust downstream strategies for next-generation biopharmaceuticals.

• Bioprocess Engineering
• Downstream Processing
• Industrial Biotechnology
• +۷ مورد دیگر

Cecilia M Thompson is an Assistant Professor in the Department of Pathology at Northwestern University Feinberg School of Medicine. She also serves as the Director of Clinical Microbiology at Ann & Robert H. Lurie Children's Hospital of Chicago, focusing on advanced molecular diagnostics and pediatric infectious diseases. BS: Loyola University Chicago (2012) MS: Loyola University Chicago (2014) PhD: Loyola University Chicago (2018) Postdoctoral Fellow: University of North Carolina Hospitals (2020) Her research centers on advanced molecular diagnostics , clinical microbiology education , and infectious diseases in immunocompromised and pediatric populations . Recent publications highlight antimicrobial therapy for MRSA bacteremia, bacterial pathogenesis, and SARS-CoV-2 symptom analysis. She maintains active professional society memberships including the Illinois Society for Microbiology, American Society for Microbiology, and Association for Molecular Pathology. Her work bridges clinical practice and academic research in pathogen detection and treatment strategies. Contact: cecilia.thompson@northwestern.edu | Location: 225 E Chicago Ave, Chicago, IL 60611

• Molecular Diagnostics
• Clinical Microbiology
• Pediatric Infectious Diseases
• +۲ مورد دیگر

Francesco Checchi is a Professor of Epidemiology and International Health at the London School of Hygiene & Tropical Medicine (LSHTM), affiliated with the Faculty of Epidemiology and Population Health and the Department of Infectious Disease Epidemiology and International Health. His expertise lies in quantitative public health measurement and disease control in crisis settings, including armed conflict, natural disasters, and epidemics. Checchi has worked with Médecins Sans Frontières, the World Health Organization, and Save the Children UK, focusing on improving health responses in humanitarian crises. He leads research on mortality estimation, vaccination strategies in displaced populations, and epidemic response evaluation. He is a member of Gavi's Partnership Team and the Equity Reference Group for Immunization. Research Interests: Mortality estimation in crisis settings, vaccination strategies in humanitarian contexts, cholera outbreak control, and the effects of conflict on health systems. He also advocates for decolonizing partnerships in global health research. Grants & Funding: Current and past grants include studies on vaccination coverage in Chad/Niger, mortality estimation in humanitarian crises, and pandemic response in crisis-affected populations. Major funders include Bill & Melinda Gates Foundation, UK Foreign Commonwealth & Development Office, and WHO. Affiliations & Activities: Member of LSHTM's Health in Humanitarian Crises Centre, Centre for Mathematical Modelling of Infectious Diseases, and Centre for Evaluation. Committee roles include Gavi's Partnership Team and UNICEF/WHO Immunization Agenda 2030 Working Group.

• Epidemiology
• Public Health
• Humanitarian Health
• +۵ مورد دیگر

Margaret Hostetter is an Adjunct Professor at Yale University's School of Medicine, serving as Physician-in-Chief at Yale-New Haven Children's Hospital and Chair of the Department of Pediatrics since 2002. She leads the Yale Child Health Research Center and specializes in pediatric infectious diseases, particularly Candida albicans and Streptococcus pneumoniae. Her research focuses on fungal pathogenesis, biofilm formation, and mechanisms of host invasion. Hostetter holds five patents and has received prestigious awards including membership in the National Academy of Sciences' Institute of Medicine. Education: Fellowship: Boston Children's Hospital, Harvard (1980) Residency/Internship: Boston Children's Hospital, Harvard (1978) Research Interests: Hostetter’s work explores Candida albicans pathogenesis, including adhesion, biofilm inhibition (e.g., via statins), and interactions with the gastrointestinal tract. Her lab investigates mitochondrial proteome roles in fungal morphogenesis and E-cadherin cleavage mechanisms disrupting intestinal barriers. Grants & Activities: Program Director, NIH-funded Pediatric Scientist Development Program NIH Peer Review Member (2008–2011) Former Chair, Division of Pediatric Infectious Diseases, University of Minnesota Awards: E. Mead Johnson Award for Pediatric Research Institute of Medicine Membership (2001) NIH Blue Ribbon Panel Appointment (2003) Labs/Teams: Directs the Yale Child Health Research Center, focusing on translational pediatric research and mentoring physician-scientists.

• Pediatrics
• Infectious Diseases
• Medical Mycology
• +۳ مورد دیگر

Jakob Møller-Jensen is an Associate Professor and Head of Department at the Department of Biochemistry and Molecular Biology, University of Southern Denmark. With a PhD in his field, he maintains an active research program with 67 publications to date and leads departmental operations. His research focuses on molecular microbiology with emphasis on host-pathogen interactions and pathogenic bacteria. His work primarily investigates Escherichia coli and uropathogenic strains, examining their behavior in urinary tract infections, plasmid dynamics, and bacterial morphology changes during infection processes. His research fingerprint shows strong expertise in Escherichia coli (100%), Uropathogenic Escherichia Coli (95%), Urinary Tract infections (43%), Plasmid biology (43%), RNA mechanisms (31%), Fimbria (31%), Gene Expression (29%), and Caenorhabditis Elegans models (27%). Analysis of his recent publications reveals a consistent focus on bacterial pathogenesis mechanisms, particularly how E. coli adapts to host environments, with special attention to urinary tract infections, bacterial morphology changes, and antibiotic resistance mechanisms. His work bridges fundamental molecular microbiology with clinical implications for infection treatment. Dr. Møller-Jensen has been involved in teaching Chemistry, Biology and Molecular Biology courses from 2009-2019, and has participated in numerous academic activities including conferences, workshops, and seminars. His collaborative network spans multiple countries and research institutions. His current research projects include significant funding from Lundbeckfonden on cellular senescence in cancer (2024-2029), NANOCHEM for ultrahigh resolution chemical characterization (2022-2028), metabolic regulation of mammalian DNA replication (2021-2026), and gut bacteria as biomarkers for colorectal cancer (2023-2025).

• Microbiology
• Molecular Biology
• Host-Pathogen Interactions
• +۳ مورد دیگر

Jan Petersen is a Research Fellow in the Department of Biochemistry and Molecular Biology at Monash University, within the Faculty of Medicine, Nursing and Health Sciences. His research is centered on molecular and cellular immunology, particularly focusing on T-cell responses to viral and bacterial pathogens. His research interests span Immunology , Infectious Diseases , T-cell Immunity , Immunopeptidomics , HLA Biology , and Viral Epitopes . His work explores how the immune system recognizes conserved epitopes in pathogens such as influenza B virus and SARS-CoV-2, as well as bacterial toxins like cholesterol-dependent cytolysins. The recent publications highlight a strong trend in understanding immune responses across diverse populations, including First Nations peoples, and the role of genetic polymorphisms in immune receptors like KIR3DL3. His research combines structural biology, immunogenetics, and clinical immunology to uncover mechanisms of broad-spectrum immunity. Jan Petersen has no listed scientific awards in the provided text. He collaborates extensively with leading immunologists including James Rossjohn, Anthony W. Purcell, and Katherine Kedzierska. While no direct mention of student supervision or grants is made, his active publication record in top-tier journals suggests involvement in major research initiatives and team-based science. He is part of a dynamic research network at Monash University focused on infectious disease immunity, antigen presentation, and immune modulation in both viral and bacterial contexts.

• Immunology
• Molecular Immunology
• Infectious Diseases
• +۷ مورد دیگر

Karen Kotloff, MD, is a Professor in the Department of Pediatrics at the University of Maryland School of Medicine. She serves as Head of the Division of Infectious Disease and Tropical Pediatrics and Associate Director of Clinical Studies at the Center for Vaccine Development and Global Health (CVD). Her work spans clinical practice, research leadership, and international public health initiatives. Education: BA in Psychology (Washington University, 1975), MD (Temple University School of Medicine, 1979) Secondary Appointments: Medicine, Epidemiology & Public Health Dr. Kotloff specializes in pediatric infectious diseases and vaccine development. Her research focuses on global child mortality reduction through clinical trials and epidemiological studies, particularly in developing countries. Key projects include the GEMS, VIDA, CHAMPS, and SANTE studies, addressing diarrheal diseases, pneumonia, and maternal-infant mortality prevention. Her scientific contributions have earned international recognition, including the Knight of the National Order of Mali (2005), Temple University Alumni Achievement Award (2019), and Founders' Day Research of the Year (2018). She leads multiple NIH- and Gates Foundation-funded initiatives, including Phase 3 COVID-19 vaccine trials and azithromycin distribution programs. Selected Awards Chevalier de l’Ordre National du Mali (2005) Distinguished Professor (2021) Temple University Alumni Achievement Award (2019) Founders' Day Research of the Year (2018) Baltimore Magazine’s Best Doctors (2013-2014) Alexander I. Shaeffer Teaching Award (1987-1988) Dr. Kotloff participates in international advisory committees for the Bill & Melinda Gates Foundation and the World Health Organization, advancing vaccine implementation strategies in Africa and Asia.

• Infectious Disease Epidemiology
• Vaccine Development
• Clinical Trials
• +۸ مورد دیگر

Sophie LIMOU is a Professor in Human Genetics at the University of Nantes , affiliated with the Mathematics, Informatics and Biology (MIB) department and leading Team 3 at the CR2TI (Center for Research in Transplantation and Translational Immunology) under Inserm UMR1064. Her work bridges genomics, bioinformatics, and immunology in kidney transplantation and complex disease research. Cell Biology Molecular Biology Physiology Human Genomics Big Data Bioinformatics Her research focuses on genetic epidemiology of complex diseases, integrating genomics, bioinformatics, and biostatistics to explore kidney function and pathologies in five key areas: end-stage renal disease, kidney graft survival, transplantation comorbidities, recurrent diseases post-transplantation, and living donor kidney function. She emphasizes nephrogenomics and precision medicine applications. Recent publications highlight her work in HLA typing , polygenic risk scores , and computational immunogenetics , particularly in transplantation outcomes. Tools developed include SHLARC reference panels and synthetic HLA twin models for privacy-preserving data sharing. She actively collaborates with international consortia and welcomes researchers to join her team at CR2TI, where she integrates multi-omics data into clinical care frameworks.

• human genetics
• genomics
• bioinformatics
• +۷ مورد دیگر